Skip to main navigation Skip to search Skip to main content

A PHASE 3B, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-TREATMENT GROUP, MULTICENTER EFFICACYAND SAFETY STUDY OF TOPICAL DILTIAZEM HYDROCHLORIDE 2% CREAM IN SUBJECTS WITH ANAL FISSURE

Project: Research

Project Details

StatusFinished
Effective start/end date11/14/12 → 11/14/14

Funding

  • Ventrus Biosciences: $5,750.00